DUBLIN--(BUSINESS WIRE)--The "Dermacosmetics Market Research Report: By Product, Treatment, Distribution Channel, End-User, Regional Insight - Global Industry Analysis and Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
This is ascribed to the growing incidence of skin diseases and a wide range of skincare products available in the market. Further, on the basis of end user, clinics, medical spas, and salons, at-home and hospitals are the classifications of the dermacosmetics market. Out of these, in 2018, the clinics, medical spas, and salons classification held the dominating revenue share of more than 45.0% in the market as compared to the at-home classification's market share of 33.8%. This is attributed to the significant number of skin treatment procedures done at such places.
The Asia-Pacific (APAC) dermacosmetics market is predicted to advance at a 7.8% CAGR during the forecast period. The main reason behind the growth of the market in this region would be the improving economic conditions, dynamic lifestyle patterns, growing disposable income, surging awareness on dermacosmetics, and significant presence of regional players. In APAC, owing to the rising incidence of skin disorders, the amount of money spent on skin treatment has also increased. As per the Organisation for Economic Cooperation and Development (OECD), in 2017, Japan's personal spending reached $2,874.0 billion from $2,833.0 billion in 2016.
Similarly, personal spending increased from $880.0 billion in 2016 to $914.0 billion in 2017 in South Korea, which raised the consumption of dermacosmetics in the region. Further, key players operating in the dermacosmetics market are introducing innovative solutions and technologies to increase their market presence. For instance, in April 2019, the U.S. Food and Drug Administration (USFDA) approved the halobetasol propionate and tazarotene lotion, DUOBRII, manufactured by Bausch Health Companies Inc. The product has been permitted for the topical treatment of plaque psoriasis in adults.
With the DUOBRII approval, patients going through plaque psoriasis now have an effective topical treatment choice that combines tazarotene and halobetasol propionate, with accepted safety profiles, into a single lotion displaying dual mechanisms of action. Besides, in February 2019, L'Oreal S.A. introduced a digital skin diagnostic technology, which became possible with the acquisition of an artificial intelligence and augmented reality firm, Modiface Inc. Bausch Health Companies Inc., Allergan plc, Procter & Gamble (P&G), and Unilever Group are some of the major players operating in the dermacosmetics market.
- Allergan plc
- Bausch Health Companies Inc.
- The Procter & Gamble Company
- Johnson & Johnson
- L'Oreal S.A.
- Unilever Group
- Beiersdorf AG
- The Este Lauder Companies Inc.
- Pierre Fabre S.A.
- Galderma S.A.
- ZO Skin Health Inc.
- Shiseido Co. Ltd.
- Amorepacific Corporation
- Sebapharma GmbH & Co. KG
- Dermtek Pharma Inc.
- Phyto Botanical Power
- Zorah Biocosmetiques
- BCG BADAN-BADAN COSMETICS GROUP GMBH
- Dr. med. Christine Schrammek Kosmetik GmbH & Co. KG
- Uriage Dermatological Laboratories
- Youth Lab Dermacosmetics
- Nuxe Laboratory
- Kanebo Cosmetics Inc.
- hysicians Care Alliance LLC
For more information about this report visit https://www.researchandmarkets.com/r/73a4uz